Module XXV - Information Resources for Specialists in Poison Information - PART I

INTRODUCTION

Welcome to the American Association of Poison Control Center’s electronic continuing education program for Specialists in Poison Information.   This fourteen-day module will cover a review of information resources available to Specialists in Poison Information.
release date - 9/4/99
most recent review date - 9/4/99
 

LEARNING OBJECTIVES

Upon completion of this electronic continuing education module, the participant will be able to:

1. Explain several potential limitations associated with the Micromedex products;

2. List several references one could use to find out information about adverse effects of medications;

3. List several references that contain information regarding “natural products”.
 

AUTHOR

Bruce Ruck, PharmD
 

REVIEW PANEL

Peter Ciancaglini, PharmD
Daniel J. Cobaugh, PharmD
Prashant Joshi, MD
Ruth Lawrence, MD
Christine Stork, PharmD
Paul Wax, MD
 

REFERENCES

Ascione F.  IPrinciples of Drug Information and Scientific Literature Evaluation.  Drug Intelligence Publications, 1994.

American Hospital Formulary Service, American Society of Health-System Pharmacists, 1999.

Barone M.  Harriet Lane Handbook 14 ed. Mosby, 1996.

Blumenthal M.  The Complete German Commission E Monographs:  Therapeutic Guide To Herbal Medicines. American Botanical Council,  1998.

Briggs GG, Freeman RK, Sumner J. Yaffe SJ   Drugs In Pregnancy and Lactation, 5 ed.  Williams & Wilkins, 1998.

DerMarderosian A.  The Review of Natural Products.  Facts and Comparisons, St. Louis.

Dukes MNG.  Meyler's Side Effects of Drugs, 12 ed. Elsevier Pub., 1992.

Ellenhorn M.  Ellenhorn’s Medical Toxicology:  Diagnois and Treatment of Human Poisoning 2 ed.  Williams & Wilkins, 1997.

Drug Facts and Comparisons, Burnham T et al., eds. Facts and Comparisons, Inc. St. Louis.

Food and Drug Administration  Website http://www.fda.gov/default.htm

Henry G.  Lithium.  Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS eds.   Goldfrank’s: Toxicologic Emergencies.  Stamford: Appleton & Lange;1998:967-74.
 

Hansten P, Horn J.  Hansten’s and Horn’s Drug Interactions Analysis and Management.  Applied Therapeutics.

Micromedex(R) Healthcare Series:  MICROMEDEX Inc., Englewood, Colorado.

Medline: National Library of Medicine http://www.nlm.nih.gov/databases/databases.html MMWR”: CDC- http://www.cdc.gov/

Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook.  4 ed. Lexicomp Inc., 1998.

Physicians’ Desk Reference 53 ed. Medical Economics Co.  NJ, 1999.

Trissel L.   Handbook of Injectable Drugs. American Society of Health-System Pharmacists, 9 ed. 1996.

Watanabe AS, Conner CS.  Principals of Drug Information Services, Drug Intelligence Publications, 1978.

USP Dictionary of USAN and International Drug Names.  USP, 1999.
 

AUTHOR DECLARATION INFORMATION

As an accredited CME sponsor, the University of Rochester Office of Continuing Professional Education requires that its authors comply with ACCME Standards for Commercial Support of CME.   All authors are required to disclose any significant financial interest or relationship that they may have with a supporting company or the manufacturer(s) of any commercial product/service that will be discussed in the materials they present.
 

ACCME STANDARDS OF COMMERCIAL SUPPORT OF CME

These standards require that materials be free of commercial bias and that any information regarding commercial products/services be based on scientific methods generally accepted by the medical community.  When discussing therapeutic options, it is our preference that only generic names be used.  If it is necessary to use a trade name, then those of several companies must be used.  Further, should the presentation include discussion of any unlabelled or investigational use of a commercial product, the author required to disclose this to the reader.
 

AUTHOR   DECLARATIONS

NO DISCLOSURES have been made by the author(s) of this module that could be perceived as a real or apparent conflict of interest in the context of the subject of their presentation(s).
 
 
 
 

Back to Program Summary

CERTIFICATION

The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

The University of Rochester School of Medicine and Dentistry designates this educational activity for a maximum of 3.0 hours in Category 1 credit towards the AMA Physician's Recognition Award.  Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

This CME activity was planned and produced in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education.